INTELLIPHARMACEUTICS INTERNATIONAL INC. Convertible Debt, Current
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Convertible Debt, Current of $1.80 million as of 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2023-10-16
- 2018-11-30: Convertible Debt, Current 1.79M CAD.
- 2017-11-30: Convertible Debt, Current 1.29M CAD.
- 2017-05-31: Convertible Debt, Current 1.27M CAD.
- 2017-02-28: Convertible Debt, Current 1.32M CAD.
CAD
| Period end | Convertible Debt, Current |
|---|---|
| 2018-11-30 | 1.79M CAD 20-F · filed 2019-03-04 |
| 2017-11-30 | 1.29M CAD 20-F · filed 2019-03-04 |
| 2017-05-31 | 1.27M CAD 6-K · filed 2017-07-11 |
| 2017-02-28 | 1.32M CAD 6-K · filed 2017-04-12 |
| 2016-11-30 | 1.49M CAD 20-F · filed 2018-03-01 |
| 2015-11-30 | 1.52M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Convertible Debt, Current |
|---|---|
| 2023-08-31 | $1.80M 6-K · filed 2023-10-16 |
| 2023-05-31 | $1.80M 6-K · filed 2023-09-26 |
| 2022-11-30 | $1.80M 6-K · filed 2023-10-16 |
| 2021-08-31 | $1.71M 6-K · filed 2021-10-15 |
| 2021-05-31 | $1.68M 6-K · filed 2021-07-15 |
| 2021-02-28 | $1.77M 6-K · filed 2021-04-14 |
| 2020-11-30 | $1.79M 6-K · filed 2021-10-15 |
| 2020-08-31 | $1.77M 6-K · filed 2020-10-15 |
| 2020-05-31 | $1.77M 6-K · filed 2020-07-15 |
| 2020-02-29 | $1.71M 6-K · filed 2020-05-29 |
| 2019-11-30 | $1.74M 20-F · filed 2021-03-31 |
| 2019-08-31 | $1.53M 6-K · filed 2019-10-11 |
| 2019-05-31 | $1.51M 6-K · filed 2019-07-10 |
| 2019-02-28 | $1.50M 6-K · filed 2019-04-15 |
| 2018-11-30 | $1.79M 20-F · filed 2020-03-30 |
| 2018-08-31 | $1.34M 6-K · filed 2018-10-15 |
| 2018-05-31 | $1.32M 6-K · filed 2018-07-24 |
| 2017-11-30 | $1.29M 6-K · filed 2018-10-15 |
| 2015-11-30 | $1.52M 20-F · filed 2016-03-21 |
| 2014-11-30 | $1.38M 20-F · filed 2016-03-21 |
| 2014-02-28 | $1.40M 6-K · filed 2014-04-14 |
| 2013-11-30 | $2.11M 20-F · filed 2015-02-27 |